For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Pulmonary artery catheterization is a diagnostic procedure in which a small catheter is inserted through a neck, arm, chest, or thigh vein and maneuvered into the right side of the heart, in order to measure pressures at different spots in the heart.
LPI (LP Information)' newest research report, the "Pulmonary Artery Catheter Industry Forecast" looks at past sales and reviews total world Pulmonary Artery Catheter sales in 2022, providing a comprehensive analysis by region and market sector of projected Pulmonary Artery Catheter sales for 2023 through 2029. With Pulmonary Artery Catheter sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pulmonary Artery Catheter industry.
This Insight Report provides a comprehensive analysis of the global Pulmonary Artery Catheter landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pulmonary Artery Catheter portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pulmonary Artery Catheter market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pulmonary Artery Catheter and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pulmonary Artery Catheter.
The global Pulmonary Artery Catheter market size is projected to grow from US$ 1155.6 million in 2022 to US$ 1504.2 million in 2029; it is expected to grow at a CAGR of 1504.2 from 2023 to 2029.
USA is the largest market with about 60% market share. Germany is follower.
The main manufacturers are Edwards Lifesciences Corporation, Argon Medical, ICU Medical, Biosensors International, BD etc. Edwards Lifesciences Corporation is the largest manufacturer with about 30% market share.
This report presents a comprehensive overview, market shares, and growth opportunities of Pulmonary Artery Catheter market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Four-lumen Catheter
- Five-lumen Catheter
- Six-lumen Catheter
- Others
Segmentation by application
- ICUs
- Non-ICUs
This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- Edwards Lifesciences Corporation
- Argon Medical
- ICU Medical
- Biosensors International
- BD
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pulmonary Artery Catheter market?
What factors are driving Pulmonary Artery Catheter market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pulmonary Artery Catheter market opportunities vary by end market size?
How does Pulmonary Artery Catheter break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?